Tuesday, August 16, 2022 9:20:12 PM
Volumes are down across the board as they usually are in August, we are tracking with our peers so I’m not overly concerned about recent volumes.
Where we are focused is our results and details we can control. Our quarter will be out by the end of August and the market will have time to digest the results before September, setting us up well to be in focus when investors return from vacation.
We are working through the consolidation process and will decide on timing in the not-too-distant future.
With respect to analysts, I am in contact with all the key players. Unfortunately, when the cannabis market came off most investment banks high graded their coverage lists to large cap US MSO and others went sector specific with their large cap coverage. I am hopeful we will gain some attention with the results and be able to drag another analyst to focusing on TGOD.
Shane
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM